Schedule 13G ownership disclosure

Evolent Health Inc

Class A Common Stock · CUSIP: 30050B101

Event date: 2026-09-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rubicon Fund II LP

    Shares: 4,947,404.00 · Class: 4.38%

  • Rubicon Fund II PF LP

    Shares: 693,719.00 · Class: 0.61%

  • Rubicon OP GP II LP

    Shares: 5,641,123.00 · Class: 4.99%

  • Rubicon OP GP II LLC

    Shares: 5,641,123.00 · Class: 4.99%

  • Rubicon Founders LLC

    Shares: 5,641,123.00 · Class: 4.99%

  • Boehler Adam

    Shares: 5,641,123.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-26-017513
Form type
SCHEDULE 13G/A
Filer
Boehler Adam
CIK
CIK 1982325
Filed
Nov 13, 2026
Reporting period
Sep 09, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub